CAS · 357336-20-0
Product Overview
Brivaracetam is a high-purity pharmaceutical-intermediates supplied for industrial and specialty chemical applications. Contact our team for specifications, packaging options and lead times.
Product Specifications
| Appearance | White to off white powder |
|---|---|
| Assay | 98% - 102% |
| Other Largest single impurity | 0.1% max |
| R,S-Isomer | 0.15% max |
| R,R-Isomer | 0.15% max |
| S,S-Isomer | 0.3% max |
| Total impurities | 0.5% max |
| Loss by drying | 0.5% max |
| Residue on ignition | 0.1% max |
| Water | 0.5% max |
Applications
Brivaracetam is a pharmaceutical compound primarily used as an antiepileptic drug for the management of partial-onset seizures in adults and pediatric patients. It is applied in clinical settings either as monotherapy or adjunctive therapy for epilepsy treatment. In research, Brivaracetam serves as a model compound for studying synaptic vesicle protein 2A (SV2A) modulation, helping to explore mechanisms of seizure control, neuroprotection, and neurotransmitter regulation. It is also used in preclinical studies to evaluate novel formulations, delivery systems, and combination therapies targeting central nervous system disorders.
Benefits
The benefits of Brivaracetam include its high affinity and selectivity for SV2A, which contributes to effective seizure reduction with a favorable safety and tolerability profile. It exhibits rapid absorption, predictable pharmacokinetics, and minimal drug-drug interactions, making it suitable for diverse patient populations. Clinically, it helps improve seizure control, quality of life, and cognitive function in patients with epilepsy. Its neuroprotective properties and targeted mechanism of action also support ongoing research into broader neurological applications.
Conclusion
Brivaracetam is a valuable antiepileptic agent with applications in clinical therapy and neurological research. Its high efficacy, selectivity, and safety profile make it an important tool for managing partial-onset seizures and exploring SV2A-mediated pathways. By providing effective seizure control and supporting CNS research, Brivaracetam continues to play a critical role in both therapeutic and scientific contexts.
Previous
2-Chloro-7H-pyrrolo2,3-dpyrimidine丨CAS 335654-06-3
Next